These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 27273086)
1. Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review. Truffault F; de Montpreville V; Eymard B; Sharshar T; Le Panse R; Berrih-Aknin S Clin Rev Allergy Immunol; 2017 Feb; 52(1):108-124. PubMed ID: 27273086 [TBL] [Abstract][Full Text] [Related]
2. Central role of interferon-beta in thymic events leading to myasthenia gravis. Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484 [TBL] [Abstract][Full Text] [Related]
3. Thymus involvement in early-onset myasthenia gravis. Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185 [TBL] [Abstract][Full Text] [Related]
4. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis. Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863 [TBL] [Abstract][Full Text] [Related]
5. Role of miRNAs in Normal and Myasthenia Gravis Thymus. Cron MA; Guillochon É; Kusner L; Le Panse R Front Immunol; 2020; 11():1074. PubMed ID: 32587589 [TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. Berrih-Aknin S; Le Panse R J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034 [TBL] [Abstract][Full Text] [Related]
7. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review. Huang GZ; Lo YL J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018 [TBL] [Abstract][Full Text] [Related]
8. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
9. Thymic remodeling associated with hyperplasia in myasthenia gravis. Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580 [TBL] [Abstract][Full Text] [Related]
10. Comparison of juvenile and adult myasthenia gravis in a French cohort with focus on thymic histology. Truffault F; Auger L; Dragin N; Vilquin JT; Fadel E; Thomas de Montpreville V; Mansuet-Lupo A; Regnard JF; Alifano M; Sharshar T; Behin A; Eymard B; Bolgert F; Demeret S; Berrih-Aknin S; Le Panse R Sci Rep; 2024 Jun; 14(1):13955. PubMed ID: 38886398 [TBL] [Abstract][Full Text] [Related]
11. Effect of corticosteroids on the thymus in myasthenia gravis. Craven C; Reddy PK; Ringel SP; Rutherford RB Muscle Nerve; 1981; 4(5):425-8. PubMed ID: 7290107 [TBL] [Abstract][Full Text] [Related]
12. [Thymic abnormalities in patients with myasthenia gravis]. Utsugisawa K; Nagane Y Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138 [TBL] [Abstract][Full Text] [Related]
13. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects. Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139 [TBL] [Abstract][Full Text] [Related]
14. Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis. Cron MA; Maillard S; Truffault F; Gualeni AV; Gloghini A; Fadel E; Guihaire J; Behin A; Berrih-Aknin S; Le Panse R Front Immunol; 2019; 10():539. PubMed ID: 30984166 [TBL] [Abstract][Full Text] [Related]
15. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086 [TBL] [Abstract][Full Text] [Related]
16. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. Sims GP; Shiono H; Willcox N; Stott DI J Immunol; 2001 Aug; 167(4):1935-44. PubMed ID: 11489973 [TBL] [Abstract][Full Text] [Related]
18. miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids. Bortone F; Scandiffio L; Marcuzzo S; Bonanno S; Frangiamore R; Motta T; Antozzi C; Mantegazza R; Cavalcante P; Bernasconi P Front Immunol; 2020; 11():142. PubMed ID: 32210951 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis. Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]